
Inflammatory Bowel Disease in Children With Systemic Juvenile Idiopathic Arthritis
Author(s) -
Justine Maller,
Emily J. Fox,
K T Park,
Sarah Sertial Paul,
Kevin Baszis,
Charlotte Borocco,
Sampath Prahalad,
Pierre Quartier,
Adam Reinhardt,
Dieneke Schonenberg-Meinema,
Lauren Shipman-Duensing,
Maria Teresa Terreri,
Julia F. Simard,
Idit Lavi,
Elizabeth Candell Chalom,
Joyce Hsu,
Devy Zisman,
Elizabeth Mellins,
Carra Legacy Registry Investigators
Publication year - 2020
Publication title -
the journal of rheumatology/journal of rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.577
H-Index - 178
eISSN - 1499-2752
pISSN - 0315-162X
DOI - 10.3899/jrheum.200230
Subject(s) - medicine , inflammatory bowel disease , etanercept , macrophage activation syndrome , arthritis , cohort , population , crohn's disease , disease , immunology , tumor necrosis factor alpha , environmental health
The incidence of inflammatory bowel disease (IBD) in juvenile idiopathic arthritis (JIA) is higher than in the general pediatric population. However, reports of IBD in the systemic JIA (sJIA) subtype are limited. We sought to characterize sJIA patients diagnosed with IBD and to identify potential contributing risk factors.